108 completed, 11 unknown, 9 recruiting, 8 withdrawn. 54 Phase 3, 29 Phase 4, 27 Phase 2, 13 Not applicable, 10 Phase 1.
Follow Beclomethasone: new trials by email Literature Review of Beclomethasone trials Research Report on Beclomethasone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg]) Beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide (100/6/12.5 µg per actuation), Foster® 200/6 pMDI (BDP/FF-200/6 µg) - Asthma | Phase 4 | Recruiting | Chiesi Farmaceutici S.p.A. | 644 | 2026-06-28 | 2026-07-31 |
| Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma Beclometasone Dipropionate and Formoterol Inhalation Aerosol, FOSTER® - Asthma (Diagnosis) | Phase 3 | Recruiting | Lunan Better Pharmaceutical Co., LTD. | 416 | 2026-06-08 | 2026-08-17 |
| VENTURI (VENTilation Using Respiratory Imaging) Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate pMDI, Fluticasone Furoate/Umeclidinium/Vilanterol 100 MCG/1 ACTUATION-62.5 MCG/1 ACTUATION-25 MCG/1 ACTUATION Inhalation Powder - Asthma | Phase 2 | Recruiting | University of Alabama at Birmingham | 20 | 2026-03-15 | 2026-04-13 |
| Betamethasone Phonophoresis For Vitiligo Beclomethasone - Vitiligo | Not applicable | Recruiting | Cairo University | 60 | 2025-11-10 | 2025-12-05 |
| Therapeutic Relevance of Abnormal Airway Morphology in Asthma Inhaled corticosteroid (ICS), Oral Corticosteroid (OCS) - Asthma | Phase 4 | Recruiting | McMaster University | 242 | 2025-06-02 | 2025-09-11 |
| Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH) BDP/FF/G (beclometasone dipropionate/formoterol fumarate dihydrate/glycopyrronium) 172/5/9 μg - Asthma, Asthma Patients | Recruiting | Chiesi Slovenija, d.o.o. | 200 | 2024-11-04 | 2026-03-24 | |
| CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma Salbutamol, Fluticason either Beclometasone or Budesonide - Asthma | Phase 2 | Unknown | Università degli Studi di Ferrara | 80 | 2024-06-18 | 2024-07-03 |
| Anti-Inflammatory Reliever South Africa Budesonide/formoterol, standard of care - Asthma | Phase 3 | Recruiting | University of KwaZulu | 1038 | 2024-06-06 | 2026-01-15 |
| Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure Vilanterol / Umeclidinium (25/62.5 mcg), Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg), Beclomethasone / Formoterol / Glycopyrronyum 100/6/12.5 mcg - COPD Bronchitis, Pollution Related Respiratory Disorder | Phase 4 | Unknown | National Institute of Respiratory Diseases, Mexico | 128 | 2023-11-15 | 2024-08-26 |
| Directed Topical Drug Delivery for Treatment for PASC Hyposmia Beclomethasone, Placebo, Microsponge - Post Acute Sequelae Covid-19 Hyposmia | Phase 2 | Completed | Duke University | 16 | 2023-09-05 | 2026-03-19 |
| Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study Beclometasone/Formoterol/Glycopyrronium 88 µg/5 µg/9 µg DPI (Trimbow® 88 µg/5 µg/9 µg in NEXThaler device) - COPD | Unknown | Chiesi SAS | 500 | 2023-08-01 | 2024-03-13 | |
| Biomarkers for Predicting the Response to Inhaled Corticosteroid in Patients With Chronic Cough. Beclometasone Dipropionate and Formoterol Inhalation Aerosol, Placebo - Cough | Not applicable | Completed | The First Affiliated Hospital of Guangzhou Medical University | 502 | 2023-04-01 | 2026-02-18 |
| A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV) CHF5993, CHF5259, Moxifloxacin 400mg - Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Completed | Chiesi Farmaceutici S.p.A. | 95 | 2023-03-29 | 2024-09-04 |
| Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease single-inhaler triple therapy (Trimbow), E-health application: Curavista app & FindAir e-device, multi-inhaler triple therapy (Qvar + Bevespi) - Copd, Adherence, Medication | Not applicable | Recruiting | Franciscus Gasthuis | 300 | 2022-12-13 | 2025-08-21 |
| Beclomethasone in Healthy Athletes Beclomethasone - Performance, Detection, Doping | Phase 4 | Unknown | Western Norway University of Applied Sciences | 30 | 2022-09-01 | 2022-04-28 |
| A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid Beclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate - Asthma | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 1377 | 2022-08-31 | 2026-07-20 |
| Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma Tapering of inhaled corticosteroid (ICS) treatment - Asthma | Phase 4 | Completed | Hvidovre University Hospital | 20 | 2022-06-01 | 2025-03-17 |
| A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD Beclomethasone Dipropionate, Glycopyrronium Bromide, Formoterol Fumarate - COPD, COPD Exacerbation | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 3406 | 2022-04-27 | 2026-09-21 |
| Study in Adult Patients With Moderate to Severe Asthma Beclomethasone dipropionate 100 µg / Formoterol fumarate 6 µg (Inhaler A), Beclomethasone dipropionate 100 µg / Formoterol fumarate 6 µg (Inhaler B) - Asthma | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 78 | 2022-02-24 | 2026-03-27 |
| BREATHE: Virtual Self-management for Long COVID-19 BREATHE - COVID-19 | Not applicable | Completed | University of Calgary | 27 | 2022-01-03 | 2022-12-14 |
Showing 20 of 143. Sign in to see all of them.
Asthma (73) · Pulmonary Disease, Chronic Obstructive (26) · Rhinitis, Allergic (10) · Rhinitis, Allergic, Seasonal (8) · Respiratory Sounds (6) · Graft vs Host Disease (5) · Lung Diseases (4) · Rhinitis, Allergic, Perennial (4) · Bronchopulmonary Dysplasia (3) · COVID-19 (3) · Lymphoma, Follicular (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Blast Crisis (2) · Bronchitis, Chronic (2) · Burkitt Lymphoma (2)
Chiesi Farmaceutici S.p.A. (34) · Teva Branded Pharmaceutical Products R&D, Inc. (16) · Research in Real-Life Ltd (7) · Organon and Co (4) · Milton S. Hershey Medical Center (3) · University of Dundee (3) · Adamis Pharmaceuticals Corporation (2) · Duke University (2) · Fred Hutchinson Cancer Center (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · National Institute of Respiratory Diseases, Mexico (2) · National Jewish Health (2) · University of Calgary (2) · Weill Medical College of Cornell University (2) · West Penn Allegheny Health System (2)
United States (48) · Poland (17) · United Kingdom (16) · Italy (15) · Canada (9) · Hungary (9) · Ukraine (9) · Bulgaria (8) · Belgium (6) · China (6) · Germany (6) · France (5) · Czechia (4) · Mexico (4) · Netherlands (4)
Alison Chisholm, MSc (3) · David Price, Prof. MD (3) · Brian Lipworth, MD (2) · Deborah A Gentile, MD (2) · Dennis Carlo (2) · Leonardo M. Fabbri, MD (2) · Maurizio A. Vignola, MD (2) · Piotr Kuna, MD (2) · Alberto Papi, MD (1) · Alberto Papi, Professor (1) · Alexandre Frederico, médico (1) · Alfredo A Chetta, MD (1) · Amanda Newton (1)
PMID 36472162, PMID 20075384, PMID 10588598, PMID 10796596, PMID 10981531, PMID 11332164, PMID 14680096, PMID 14757604, PMID 15144456, PMID 15215480, PMID 15789960, PMID 16304262, PMID 16687711, PMID 17107988, PMID 17358042, PMID 17507703, PMID 17556723, PMID 17845589, PMID 17890470, PMID 18827155, PMID 18977646, PMID 19164187, PMID 19196814, PMID 19336497, PMID 19772514, PMID 19932356, PMID 20109122, PMID 20692026, PMID 20965712, PMID 20979471, PMID 21324520, PMID 21357889, PMID 21859484, PMID 22350679, PMID 22621776, PMID 22731754, PMID 22737708, PMID 22978252, PMID 23026180, PMID 23062389, PMID 23643486, PMID 24084072, PMID 24125150, PMID 24299501, PMID 24321801, PMID 24534400, PMID 24621681, PMID 24953015, PMID 24992552, PMID 25808292
2009 (3), 2014 (2), U10HL074073 (2), U10HL074204 (2), U10HL074208 (2), U10HL074212 (2), U10HL074218 (2), U10HL074225 (2), U10HL074227 (2), U10HL074231 (2), 2004 (1), 2008 (1), 2016 (1), 2017 (1), 2019 (1)